Skip to main content
All lobbying filings

COLLIER COLLECTIVE, LLC

COLLIER COLLECTIVE, LLC filed a Q2 report for AVAC (AIDS VACCINE AND ADVOCACY COALITION) on August 16, 2025, reporting $40,000 in lobbying income.

Lobbying for AVAC (AIDS VACCINE AND ADVOCACY COALITION) · AVAC works to ensure ethical development of and access to effective HIV prevention options

All filings by COLLIER COLLECTIVE, LLC · Everything AVAC (AIDS VACCINE AND ADVOCACY COALITION) has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Aug 16, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
New York

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Advocated for Congress to ensure expenditure of FY25 appropriations and robustly appropriate funding for FY26 for HIV/AIDS treatment and prevention programs in the Health Resources and Services Administration (HRSA) and the Center for Disease Control and Prevention(CDC) at the Dept. of Health & Human Services, including the Ryan White HIV/AIDS Program (HRSA), the Ending the HIV Epidemic program (HRSA & CDC), a national pre-exposure prophylaxis (PrEP) initiative (CDC), and HIV research programs at NIH that would be appropriated through the Labor, Health & Human Services, Education, and Related Agencies appropriations bill.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem